688399 Stock Overview
A molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Jiangsu Bioperfectus Technologies Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥68.93 |
| 52 Week High | CN¥105.15 |
| 52 Week Low | CN¥49.02 |
| Beta | 0.99 |
| 1 Month Change | -15.41% |
| 3 Month Change | -13.62% |
| 1 Year Change | 24.36% |
| 3 Year Change | -44.87% |
| 5 Year Change | 20.97% |
| Change since IPO | 25.60% |
Recent News & Updates
Estimating The Intrinsic Value Of Jiangsu Bioperfectus Technologies Co., Ltd. (SHSE:688399)
Nov 27
Is Jiangsu Bioperfectus Technologies (SHSE:688399) A Risky Investment?
Oct 07Recent updates
Estimating The Intrinsic Value Of Jiangsu Bioperfectus Technologies Co., Ltd. (SHSE:688399)
Nov 27Is Jiangsu Bioperfectus Technologies (SHSE:688399) A Risky Investment?
Oct 07Is Jiangsu Bioperfectus Technologies (SHSE:688399) Using Debt In A Risky Way?
Jun 05Jiangsu Bioperfectus Technologies Co., Ltd.'s (SHSE:688399) Shares Climb 28% But Its Business Is Yet to Catch Up
Mar 25Shareholder Returns
| 688399 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -4.7% | -2.8% | -1.2% |
| 1Y | 24.4% | -9.2% | 11.8% |
Return vs Industry: 688399 exceeded the CN Medical Equipment industry which returned -10.3% over the past year.
Return vs Market: 688399 exceeded the CN Market which returned 10.9% over the past year.
Price Volatility
| 688399 volatility | |
|---|---|
| 688399 Average Weekly Movement | 6.9% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 688399 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688399's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 645 | Guoqiang Wang | www.s-sbio.com |
Jiangsu Bioperfectus Technologies Co., Ltd., a molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China. It offers in vitro diagnostic reagents and supporting testing equipment, as well as in vitro testing services. The company was founded in 2010 and is headquartered in Taizhou, China.
Jiangsu Bioperfectus Technologies Co., Ltd. Fundamentals Summary
| 688399 fundamental statistics | |
|---|---|
| Market cap | CN¥3.91b |
| Earnings (TTM) | -CN¥170.68m |
| Revenue (TTM) | CN¥394.83m |
9.9x
P/S Ratio-22.9x
P/E RatioIs 688399 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688399 income statement (TTM) | |
|---|---|
| Revenue | CN¥394.83m |
| Cost of Revenue | CN¥235.77m |
| Gross Profit | CN¥159.07m |
| Other Expenses | CN¥329.75m |
| Earnings | -CN¥170.68m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.01 |
| Gross Margin | 40.29% |
| Net Profit Margin | -43.23% |
| Debt/Equity Ratio | 9.5% |
How did 688399 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 05:16 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jiangsu Bioperfectus Technologies Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|